157 related articles for article (PubMed ID: 16041272)
1. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Jul; 80(2):255-63. PubMed ID: 16041272
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
4. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
Ozkaynak E; Gao W; Shemmeri N; Wang C; Gutierrez-Ramos JC; Amaral J; Qin S; Rottman JB; Coyle AJ; Hancock WW
Nat Immunol; 2001 Jul; 2(7):591-6. PubMed ID: 11429542
[TBL] [Abstract][Full Text] [Related]
5. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Brook MO; Jones ND; Wood KJ
Transplantation; 2005 Jul; 80(2):253-4. PubMed ID: 16041271
[No Abstract] [Full Text] [Related]
7. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
Guillonneau C; Hill M; Hubert FX; Chiffoleau E; Hervé C; Li XL; Heslan M; Usal C; Tesson L; Ménoret S; Saoudi A; Le Mauff B; Josien R; Cuturi MC; Anegon I
J Clin Invest; 2007 Apr; 117(4):1096-106. PubMed ID: 17404623
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients.
Guillonneau C; Séveno C; Dugast AS; Li XL; Renaudin K; Haspot F; Usal C; Veziers J; Anegon I; Vanhove B
J Immunol; 2007 Dec; 179(12):8164-71. PubMed ID: 18056359
[TBL] [Abstract][Full Text] [Related]
9. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
[TBL] [Abstract][Full Text] [Related]
10. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
[TBL] [Abstract][Full Text] [Related]
11. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation.
Guo L; Li XK; Enosawa S; Funeshima N; Suzuki S; Kimura H; Sugawara Y; Tezuka K; Makuuchi M
Liver Transpl; 2004 Jun; 10(6):743-7. PubMed ID: 15162468
[TBL] [Abstract][Full Text] [Related]
12. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
13. AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Int; 2004 Jan; 17(1):15-21. PubMed ID: 12942167
[TBL] [Abstract][Full Text] [Related]
14. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.
Angin M; Poirier N; Dilek N; Le Guiner C; Toromanoff A; Blancher A; Cherel Y; Deschamps JY; Tillou X; Renaudin K; Minault D; Hervouet J; Blancho G; Vanhove B; Anegon I; Le Mauff B
Transpl Immunol; 2012 Dec; 27(4):139-45. PubMed ID: 23098770
[TBL] [Abstract][Full Text] [Related]
16. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.
Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Lea W; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Xenotransplantation; 2005 May; 12(3):197-208. PubMed ID: 15807770
[TBL] [Abstract][Full Text] [Related]
17. Transfection of CD40Ig into liver prevents acute rejection in rat liver transplantation.
Zhu JY; Liu YN; Wang D; Li T; Leng XS
Transplant Proc; 2005 Dec; 37(10):4571-4. PubMed ID: 16387173
[TBL] [Abstract][Full Text] [Related]
18. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
